ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Tade Brad L. | CFO and Treasurer | Nov 22 '24 | Sale | 21.15 | 15,000 | 317,250 | 199,433 | Nov 22 09:05 PM | Grossman Adam S | President and CEO | Nov 22 '24 | Sale | 21.10 | 48,967 | 1,033,204 | 1,989,007 | Nov 22 09:05 PM | Grossman Adam S | Director and Officer | Nov 22 '24 | Proposed Sale | 21.30 | 48,967 | 1,042,997 | | Nov 22 09:00 PM | Tade Brad L. | Officer | Nov 22 '24 | Proposed Sale | 21.30 | 15,000 | 319,500 | | Nov 22 09:00 PM | Guiheen Lawrence P. | Director | Sep 09 '24 | Option Exercise | 10.80 | 9,000 | 97,200 | 162,941 | Sep 11 09:00 PM | Guiheen Lawrence P. | Director | Sep 09 '24 | Sale | 18.47 | 9,000 | 166,189 | 153,941 | Sep 11 09:00 PM | Guiheen Lawrence P. | Director | Sep 09 '24 | Proposed Sale | 16.26 | 9,000 | 146,340 | | Sep 09 09:00 PM | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Aug 30 '24 | Option Exercise | 3.87 | 24,150 | 93,526 | 473,238 | Aug 30 09:05 PM | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Aug 30 '24 | Sale | 16.90 | 24,150 | 408,050 | 449,088 | Aug 30 09:05 PM | Grossman Jerrold B | Director | Aug 29 '24 | Option Exercise | 4.28 | 136,861 | 585,871 | 604,166 | Aug 30 09:02 PM | Grossman Jerrold B | Director | Aug 29 '24 | Sale | 17.27 | 136,861 | 2,363,932 | 467,305 | Aug 30 09:02 PM | Kestenberg-Messina Kaitlin M. | Officer | Aug 30 '24 | Proposed Sale | 17.22 | 24,150 | 415,863 | | Aug 30 09:00 PM | Grossman Jerrold B | Director | Aug 29 '24 | Proposed Sale | 17.24 | 136,861 | 2,359,484 | | Aug 29 09:26 PM | Grossman Adam S | President and CEO | Aug 26 '24 | Option Exercise | 6.84 | 236,889 | 1,619,466 | 2,296,615 | Aug 27 09:22 PM | Grossman Adam S | President and CEO | Aug 27 '24 | Option Exercise | 3.30 | 389,356 | 1,283,725 | 2,449,082 | Aug 27 09:22 PM | Grossman Adam S | President and CEO | Aug 27 '24 | Sale | 17.29 | 389,356 | 6,732,900 | 2,059,726 | Aug 27 09:22 PM | Grossman Adam S | President and CEO | Aug 26 '24 | Sale | 17.69 | 236,889 | 4,191,088 | 2,059,726 | Aug 27 09:22 PM | KWON YOUNG | Director | Aug 23 '24 | Sale | 18.26 | 60,000 | 1,095,600 | 241,441 | Aug 27 09:00 PM | Grossman Adam S | Officer | Aug 26 '24 | Proposed Sale | 18.20 | 626,245 | 11,397,659 | | Aug 26 09:28 PM | Grossman Adam S | President,CEO, and Interim CFO | Jun 14 '24 | Sale | 10.72 | 100,000 | 1,071,980 | 2,081,475 | Jun 14 09:00 PM | ELMS STEVE | Director | Mar 19 '24 | Sale | 6.08 | 411,829 | 2,503,920 | 2,115,671 | Mar 19 09:48 PM | ELMS STEVE | Director | Mar 18 '24 | Sale | 6.01 | 49,887 | 299,821 | 2,527,500 | Mar 19 09:48 PM | ELMS STEVE | Director | Mar 14 '24 | Sale | 6.05 | 448,276 | 2,712,070 | 2,760,395 | Mar 15 09:00 PM | ELMS STEVE | Director | Mar 13 '24 | Sale | 6.21 | 407,000 | 2,527,470 | 3,208,671 | Mar 15 09:00 PM | ELMS STEVE | Director | Mar 15 '24 | Sale | 6.01 | 183,008 | 1,099,878 | 2,577,387 | Mar 15 09:00 PM |
|